rediff.com
e.g. Tata motors, Reliance MF, 500570
Piramal Pharma Ltd. - Research Center
543635 PPLPHARMA Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21
Sales 1,840.67 1,575.34 1,677.75 1,417.20
Operating profit 102.75 -19.29 241.96 155.34
Interest 62.02 48.87 31.18 22.37
Gross profit 156.49 156.15 341.74 225.60
EPS (Rs) 0.33 0.25 2.01 1.05
Half yearly  results in details
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21
Other income 115.76 224.31 130.96 92.63
Stock adjustment -76.64 -16.27 37.68 -67.85
Raw material 683.09 578.73 392.52 611.16
Power and fuel - - - -
Employee expenses 310.49 270.20 199.18 226.12
Excise - - - -
Admin and selling expenses - - - -
Research and development expenses - - - -
Expenses capitalised - - - -
Other expenses 820.98 761.97 806.41 492.43
Provisions made - - - -
Depreciation 101.20 91.89 57.31 73.33
Taxation 11.49 27.09 48.34 32.84
Net profit / loss 43.80 30.21 238.70 104.35
Extra ordinary item - -6.96 2.61 -15.08
Prior year adjustments - - - -
Equity capital 1,322.95 1,193.32 1,185.91 994.60
Equity dividend rate - - - -
Agg.of non-prom. shares (Lacs) - - - -
Agg.of non promotoholding (%) - - - -
OPM (%) 5.58 -1.22 14.42 10.96
GPM (%) 8.00 8.68 18.89 14.94
NPM (%) 2.24 1.68 13.20 6.91
Close
Add Piramal Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Piramal Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close